PMID: 6398221Jan 1, 1984Paper

Monoclonal antibodies: the possibilities for cancer therapy

Experimental Biology
C H Poynton, C L Reading

Abstract

Previous studies and current efforts to use monoclonal antibodies in human cancer therapy are reviewed. These include antibody-dependent immune reactions in vivo, conjugation of cytotoxic agents to monoclonal antibodies, and monoclonal antibody-mediated tumor cell elimination from bone marrow in vitro for use in autologous bone marrow transplantation. Our studies describe the use of magnetic immunocolloids for the removal of leukemic cells from human bone marrow. Future possibilities for the therapeutic use of monoclonal antibodies are also discussed.

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.